Behavioral and pharmacologic therapies for obesity
نویسندگان
چکیده
منابع مشابه
Pharmacologic Therapies for Pediatric Concussions
CONTEXT Pediatric concussions are common, and emphasis on correct diagnosis and management is stressed in consensus guidelines. Medications may have a role in management of concussion, but no consensus exists regarding appropriate pharmacologic therapy. EVIDENCE ACQUISITION Nonsystematic review. STUDY DESIGN Clinical review. LEVEL OF EVIDENCE Level 4. RESULTS There is limited evidence f...
متن کاملNovel pharmacologic therapies for cystic fibrosis.
The Journal of Clinical Investigation | February 1999 | Volume 103 | Number 4 447 It has been nearly 10 years since the identification and cloning of the cystic fibrosis (CF) gene was announced (1). Despite rapid advances in our understanding of the molecular determinants of the disease, CF remains one of the most common lethal inherited autosomal recessive disorders in the Caucasian population...
متن کاملPharmacologic therapies for complex regional pain syndrome.
Complex regional pain syndrome (CRPS) remains a challenging condition to diagnose and treat. There are few large-scale, randomized trials of pharmacologic agents, and most published studies are small, uncontrolled, or presented only in abstract form at meetings. The most commonly used agents, such as anticonvulsants, antidepressants, and opiates, have been found to be useful for other neuropath...
متن کاملNon-pharmacologic therapies for atopic dermatitis.
Atopic dermatitis (AD) continues to present significant therapeutic challenges, especially in severe cases. Navigating the line between risk and benefit can be difficult for more powerful medications such as immunosuppressants, but non-pharmacologic treatments are often overlooked and underutilized. Creative application of these more physical therapies can serve to minimize the pharmacologic tr...
متن کاملPharmacologic Treatment of Obesity
This review offers an overview of physiological agents, current therapeutics, as well as medications, which have been extensively used and those agents not currently available or non-classically considered anti-obesity drugs. As obesity - particularly that of central distribution - represents an important triggering factor for insulin resistance, its pharmacological treatment is relevant in the...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Reviews Endocrinology
سال: 2010
ISSN: 1759-5029,1759-5037
DOI: 10.1038/nrendo.2010.121